O

ONWARD Medical NV
XBRU:ONWD

Watchlist Manager
ONWARD Medical NV
XBRU:ONWD
Watchlist
Price: 2.87 EUR 2.32% Market Closed
Market Cap: €160.7m

Wall St Price Targets

ONWD Price Targets Summary
ONWARD Medical NV

Wall Street analysts forecast ONWD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONWD is 9.98 EUR with a low forecast of 8.18 EUR and a high forecast of 11.87 EUR.

Lowest Forecast
Price Target
8.18 EUR
185% Upside
Average Forecast
Price Target
9.98 EUR
248% Upside
Highest Forecast
Price Target
11.87 EUR
313% Upside
ONWARD Medical NV Competitors:
Price Targets
XO
Exotic Food PCL
35% Upside
NESR
National Energy Services Reunited Corp
22% Upside
PHUN
Phunware Inc
182% Upside

Revenue
Forecast

N/A
Past Growth
153% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss
N/A
Past Growth
153% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 153%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ONWD's stock price target?
Price Target
9.98 EUR

According to Wall Street analysts, the average 1-year price target for ONWD is 9.98 EUR with a low forecast of 8.18 EUR and a high forecast of 11.87 EUR.

What is the Revenue forecast for ONWARD Medical NV?
Projected CAGR
153%

The compound annual growth rate for Revenue over the next 3 years is 153%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett